Atrial fibrillation is the most common type of cardiac arrhythmia, and is a common cause of stroke and heart failure. Currently, there is a major unmet need for drugs that are capable of successfully ...
Please provide your email address to receive an email when new articles are posted on . As the general population continues to age, atrial and ventricular arrhythmias are of a growing concern. Despite ...
Norpace CR is a Type 1 antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias. Pfizer has issued an update regarding the availability of Norpace CR (disopyramide ...
heart ecg arrhythmia The FDA has approved the Prior Approval Supplement for Bretylium Tosylate Injection, allowing ANI Pharmaceuticals to market the once discontinued antiarrhythmic agent. The Food ...
Human ether-à-go-go related gene (hERG), KCNQ and Kv1.2 channels were expressed in CHO cells. The delayed rectifier potassium current (I K) was recorded from dissociated hippocampal pyramidal neurons ...
Background: Of the antiarrhythmic agents currently marketed in Canada, 5 are commonly used to treat atrial fibrillation (AF). The impact of contraindications, warnings and precautions for the use of ...
Abstract and Introduction Drugs Used for Ventricular Rate Control Drugs Used to Restore and Maintain Sinus Rhythm Conclusions References Drugs Used for Ventricular Rate Control In AF, adequate rate ...
Previous trials reported that rhythm control for atrial fibrillation (AF) management was not superior to rate control. Rate control incurred less utilisation of healthcare resources and became the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results